MAPT and Alzheimer disease: Cerebrospinal fluid (CSF) biomarkers, such as different species of amyloid-β (Aβ), total tau (t-tau) and phosphorylated tau (p-tau), have been proven to be of great diagnostic value in the early diagnosis of AD (Lewczuk et al. 2018).